UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Immune Activation of the Central Nervous System Is Still Present after >4 Years of Effective Highly Active Antiretroviral Therapy

The Journal of infectious diseases, 2007-12, Vol.196 (12), p.1779-1783

2007

Volltextzugriff (PDF)

Neopterin as a Predictor of Total and Cardiovascular Mortality in Individuals Undergoing Angiography in the Ludwigshafen Risk and Cardiovascular Health Study

Clinical chemistry (Baltimore, Md.), 2009-06, Vol.55 (6), p.1135-1146

2009

Volltextzugriff (PDF)

More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC

Clinical chemistry (Baltimore, Md.), 2002-03, Vol.48 (3), p.579-581

2002

Volltextzugriff (PDF)

The significance of tryptophan metabolism and vitamin B-6 status in cardiovascular disease

The American journal of clinical nutrition, 2020-01, Vol.111 (1), p.8-9

2020

Volltextzugriff (PDF)

Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study

The Journal of infectious diseases, 2016-12, Vol.214 (12), p.1822-1825

2016

Volltextzugriff (PDF)

Cardioprotective effect of polyamine spermidine

The American journal of clinical nutrition, 2019-01, Vol.109 (1), p.218-218

2019

Volltextzugriff (PDF)

Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection

Clinical infectious diseases, 2018-11, Vol.67 (11), p.1697-1704

2018

Volltextzugriff (PDF)

HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment

The Journal of infectious diseases, 2010-12, Vol.202 (12), p.1819-1825

2010

Volltextzugriff (PDF)

Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy

The Journal of infectious diseases, 2017-04, Vol.215 (7), p.1132-1140

2017

Volltextzugriff (PDF)

Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV Infection

The Journal of infectious diseases, 2013-06, Vol.207 (11), p.1703-1712

2013

Volltextzugriff (PDF)

No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62)

The Journal of infectious diseases, 2021-06, Vol.223 (11), p.1928-1933

2021

Volltextzugriff (PDF)

Cerebrospinal Fluid and Plasma Lipopolysaccharide Levels in Human Immunodeficiency Virus Type 1 Infection and Associations With Inflammation, Blood-Brain Barrier Permeability, and Neuronal Injury

The Journal of infectious diseases, 2021-05, Vol.223 (9), p.1612-1620

2021

Volltextzugriff (PDF)

Central Nervous System Immune Activation Characterizes Primary Human Immunodeficiency Virus 1 Infection Even in Participants With Minimal Cerebrospinal Fluid Viral Burden

The Journal of infectious diseases, 2011-09, Vol.204 (5), p.753-760

2011

Volltextzugriff (PDF)

Cerebrospinal fluid and plasma lipopolysaccharide (LPS) levels in HIV-1 infection and associations with inflammation, blood-brain barrier permeability and neuronal injury

The Journal of infectious diseases, 2021, Vol.223 (9), p.1612

2021

Volltextzugriff (PDF)

205 Serum tryptophan and kynurenine levels are altered in systemic sclerosis patients and show distinct clinical and autoantibody associations suggesting potential role in pathogenesis

Rheumatology (Oxford, England), 2018-04, Vol.57 (suppl_3)

2018

Volltextzugriff (PDF)

Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption

Journal of antimicrobial chemotherapy, 2020-05, Vol.75 (5), p.1311-1320

2020

Volltextzugriff (PDF)

No changes in HIV suppression and inflammatory markers in CSF in patients randomly switched to DTG + 3TC (Spanish HIV/AIDS Research Network, PreEC/RIS 62)

The Journal of infectious diseases, 2021, Vol.223 (11), p.1928

2021

Volltextzugriff (PDF)

Structural Brain Abnormalities in Successfully Treated HIV Infection: Associations With Disease and Cerebrospinal Fluid Biomarkers

The Journal of infectious diseases, 2018-01, Vol.217 (1), p.69-81

2018

Volltextzugriff (PDF)

Toxoplasma gondii IgG Serointensity Is Positively Associated With Frailty

The journals of gerontology. Series A, Biological sciences and medical sciences, 2024-03, Vol.79 (3)

2024

Volltextzugriff (PDF)

Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy

The Journal of infectious diseases, 2011-12, Vol.204 (12), p.1936-1945

2011

Volltextzugriff (PDF)

Tryptophan Catabolism During Intracellular Infection

The Journal of infectious diseases, 2012-05, Vol.205 (10), p.1617-1618

2012

Volltextzugriff (PDF)

Simultaneous measurement of serum tryptophan and kynurenine by HPLC

Clinical chemistry (Baltimore, Md.), 1997-12, Vol.43 (12), p.2424-2426

1997

Volltextzugriff (PDF)

Central Nervous System Activation of the Indoleamine-2,3-Dioxygenase Pathway in Human T Cell Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis

The Journal of infectious diseases, 2000-06, Vol.181 (6), p.2037-2040

2000

Volltextzugriff (PDF)

In vitro testing for antiinflammatory properties of compounds

Clinical chemistry (Baltimore, Md.), 2006-06, Vol.52 (6), p.1201-1202

2006

Volltextzugriff (PDF)

Reply to Seligman

The Journal of infectious diseases, 2011-07, Vol.204 (1), p.174-175

2011

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAlcohol And Alcoholism

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(54)
magazinearticle
(1)

Sprache

Englisch
(55)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immune Activation of the Central Nervous System Is Still Present after >4 Years of Effective Highly Active Antiretroviral Therapy

Neopterin as a Predictor of Total and Cardiovascular Mortality in Individuals Undergoing Angiography in the Ludwigshafen Risk and Cardiovascular Health Study

More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC

The significance of tryptophan metabolism and vitamin B-6 status in cardiovascular disease

Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study

Cardioprotective effect of polyamine spermidine

Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection

HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment

Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy

Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV Infection

No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62)

Cerebrospinal Fluid and Plasma Lipopolysaccharide Levels in Human Immunodeficiency Virus Type 1 Infection and Associations With Inflammation, Blood-Brain Barrier Permeability, and Neuronal Injury

Central Nervous System Immune Activation Characterizes Primary Human Immunodeficiency Virus 1 Infection Even in Participants With Minimal Cerebrospinal Fluid Viral Burden

Cerebrospinal fluid and plasma lipopolysaccharide (LPS) levels in HIV-1 infection and associations with inflammation, blood-brain barrier permeability and neuronal injury

205 Serum tryptophan and kynurenine levels are altered in systemic sclerosis patients and show distinct clinical and autoantibody associations suggesting potential role in pathogenesis

Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption

No changes in HIV suppression and inflammatory markers in CSF in patients randomly switched to DTG + 3TC (Spanish HIV/AIDS Research Network, PreEC/RIS 62)

Structural Brain Abnormalities in Successfully Treated HIV Infection: Associations With Disease and Cerebrospinal Fluid Biomarkers

Toxoplasma gondii IgG Serointensity Is Positively Associated With Frailty

Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy

Tryptophan Catabolism During Intracellular Infection

Simultaneous measurement of serum tryptophan and kynurenine by HPLC

Central Nervous System Activation of the Indoleamine-2,3-Dioxygenase Pathway in Human T Cell Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis

In vitro testing for antiinflammatory properties of compounds

Reply to Seligman

Aktive Filter

Suchergebnisse filtern